p300-mediated inhibition of doxorubicin-induced myocardial cell apoptosis involves ubiquitin-dependent p53 degradation

被引：0
|
作者：
Morimoto, Tatsuya
Kita, Toru
Kawamura, Teruhisa
Wada, Hiromichi
Sunagawa, Yoichi
Hasegawa, Koji
Fujita, Masatoshi
机构：
[1] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[2] Natl Hosp Org, Kyoto Med Ctr, Kyoto, Japan
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [1] p300-mediated inhibition of doxorubicin-induced myocardial cell apoptosis involves ubiquitin-dependent p53 degradation
    Morimoto, T
    Ono, K
    Kawamura, T
    Kita, T
    Hasegawa, K
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S289 - S289
  • [2] P300-mediated inactivation of p53 protects against doxorubicin-induced cardiotoxicity
    Adam, M.
    Singh, K. K.
    Connelly, K. A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3318 - 3318
  • [3] Myocardial regulation of p300 and p53 by doxorubicin involves ubiquitin pathways
    Morimoto, Tatsuya
    Fujita, Masatoshi
    Kawamura, Teruhisa
    Sunagawa, Yoichi
    Takaya, Tomohide
    Wada, Hiromichi
    Shimatsu, Akira
    Kita, Toru
    Hasegawa, Koji
    CIRCULATION JOURNAL, 2008, 72 (09) : 1506 - 1511
  • [4] Diacylglycerol Kinase ζ Attenuates Doxorubicin-Induced Cardiotoxicity Through p53 Degradation
    Tachibana, Shingo
    Otaki, Yoichiro
    Watanabe, Tetsu
    Goto, Jun
    Ochi, Haruki
    Tanaka, Toshiaki
    Ono, Hiroe
    Yamaguchi, Ryuhei
    Sato, Junya
    Takahashi, Hiroki
    Arimoto, Takanori
    Goto, Kaoru
    Watanabe, Masafumi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (01):
  • [5] Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen
    Lee, YS
    Wan, J
    Kim, BJ
    Bae, MA
    Song, BJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (01): : 202 - 208
  • [6] ERK1/2/p53 and NF-κB dependent-PUMA activation involves in doxorubicin-induced cardiomyocyte apoptosis
    Zhang, D. -X.
    Ma, D. -Y.
    Yao, Z. -Q.
    Fu, C. -Y.
    Shi, Y. -X.
    Wang, Q. -L.
    Tang, Q. -Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (11) : 2435 - 2442
  • [7] Myocardial expression of mutant p53 protects against doxorubicin-induced cardiomyocyte apoptosis and preserves heart function
    Zhu, W.
    Field, L. J.
    PEDIATRIC RESEARCH, 2006, 60 (04) : 493 - 493
  • [8] Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305
    Wang, YH
    Tsay, YG
    Tan, BCM
    Lo, WY
    Lee, SC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) : 25568 - 25576
  • [9] UBE2C promotes LUAD progression by ubiquitin-dependent degradation of p53 to inactivate the p53/p21 signaling pathway
    Huang, Siyuan
    Li, Xingya
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [10] A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
    H-J Tang
    D Qian
    V K Sondak
    S Stachura
    J Lin
    British Journal of Cancer, 2004, 90 : 1285 - 1292
12345